Education
About Us
Working with TipRanks
Follow Us
Y-Mabs Therapeutics (YMAB)
NASDAQ:YMAB
Y-Mabs Therapeutics (YMAB) Ownership Overview
17.08% Insiders
7.96% Mutual Funds
0.10% Other Institutional Investors
8.71% ETFs
66.15% Public Companies and Individual Investors
The ownership structure of Y-Mabs Therapeutics (YMAB) stock is a mix of institutional, retail, and individual investors. Approximately 16.77% of the company’s stock is owned by Institutional Investors, 17.08% is owned by Insiders, and 66.15% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Mar 11, 2025 | xxxxxxxxxxxxx | $56536 | |
Mar 11, 2025 | xxxxxxxxxxxxx | $20368 | |
Sep 17, 2024 | xxxxxxxxxxxxx | $1264650 | |
Aug 30, 2024 | xxxxxxxxxxxxx | $768500 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Mar 31, 2025 | xxxxxxxxxxxxx | $56057 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 4,590,138 | Insider | 10.13% | 20,013,002 | |
| 2,250,961 | Insider | 4.97% | 9,814,190 | |
| 1,848,829 | Institution | 4.08% | 8,060,894 | |
| 1,589,558 | Institution | 3.51% | 6,930,473 | |
| 1,540,964 | Institution | 3.40% | 6,718,603 | |
| 433,402 | Insider | 0.96% | 1,889,633 | |
| 418,872 | Institution | 0.92% | 1,826,282 | |
| 339,030 | Institution | 0.75% | 1,478,171 | |
| 220,831 | Institution | 0.49% | 962,823 | |
| 209,064 | Institution | 0.46% | 911,519 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,540,964 | Institution | 3.40% | 6,718,603 | |
| 418,872 | Institution | 0.92% | 1,826,282 | |
| 339,030 | Institution | 0.75% | 1,478,171 | |
| 220,831 | Institution | 0.49% | 962,823 | |
| 209,064 | Institution | 0.46% | 911,519 | |
| 188,163 | Institution | 0.42% | 820,391 | |
| 145,513 | Institution | 0.32% | 634,437 | |
| 104,853 | Institution | 0.23% | 457,159 | |
| 98,087 | Institution | 0.22% | 427,659 | |
| 55,000 | Institution | 0.12% | 239,800 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,040,061 | Institution | 2.30% | 4,784,281 | |
| 918,749 | Institution | 2.03% | 4,005,746 | |
| 500,903 | Institution | 1.11% | 2,304,154 | |
| 314,324 | Institution | 0.69% | 1,370,453 | |
| 219,287 | Institution | 0.48% | 956,091 | |
| 187,528 | Institution | 0.41% | 862,629 | |
| 155,674 | Institution | 0.34% | 678,739 | |
| 84,645 | Institution | 0.19% | 389,367 | |
| 81,372 | Institution | 0.18% | 354,782 | |
| 69,367 | Institution | 0.15% | 302,440 |
FAQ
Who Owns Y-Mabs Therapeutics (YMAB)?
According to the latest TipRanks data, approximately 0.10% of the company's stock is held by institutional investors, 17.08% is held by insiders, and 66.15% is held by retail investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.10% of Y-Mabs Therapeutics (YMAB) stock is held by institutional investors.
What percentage of Y-Mabs Therapeutics (YMAB) stock is held by retail investors?
According to the latest TipRanks data, approximately 66.15% of Y-Mabs Therapeutics (YMAB) stock is held by retail investors.
Who owns the most shares of Y-Mabs Therapeutics (YMAB)?
Johan Wedell-Wedellsborg owns the most shares of Y-Mabs Therapeutics (YMAB).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.